Nutra Pharma (Nutra Pharma) 3-Year EBITDA Growth Rate : 0.00% (As of Sep. 2022)

View and export this data going back to . Start your Free Trial

What is Nutra Pharma 3-Year EBITDA Growth Rate?

Nutra Pharma's EBITDA per Share for the three months ended in Sep. 2022 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of Nutra Pharma's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Nutra Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nutra Pharma's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nutra Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Nutra Pharma's 3-Year EBITDA Growth Rate falls into.

Nutra Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Nutra Pharma (OTCPK:NPHC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Nutra Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Nutra Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nutra Pharma (Nutra Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nutra Pharma Corp (OTCPK:NPHC) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1537 NW 65th Avenue, Plantation, FL, USA, 33313

Website

https://www.nutrapharma.com

Nutra Pharma Corp operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. It also develops proprietary therapeutic protein products primarily for the prevention and treatment of viral and neurological diseases, including Multiple Sclerosis (MS), Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), and pain in humans. Some of its drug names are Cobroxin, Nyloxin, RPI-78M, RPI-MN and Pet Pain-Away.

Executives

Rik J Deitsch	officer: Chief Executive Officer	4001 NW 73 WAY, CORAL SPRINGS FL 33065
Dan Oran	director	8411 W OAKLAND PARK BLVD, #201, SUNRISE FL 33351
Bruno Sartori	other: Former CFO	275 COMMERCIAL BLVD, STE 260, FT LAUDERDALE FL 33308
Harold Henry Rumph	director, officer: President - ReceptoPharm	1537 N.W. 65TH AVENUE, PLANTATION FL 33313
David Michael Isserman	officer: Chief Marketing Officer	2776 UNIVERSITY DRIVE, CORAL SPRINGS FL 33065
Garry Pottruck	director	10768 NW 18TH CT, CORAL SPRINGS FL 33071
Paul F Reid	director	9610 NW 24 CT, SUNRISE FL 33322
Michael Doherty	director, officer: Executive Chairman
Tanvir A Khandaker	director	387 PARK AVENUE SOUTH THIRD FLOOR, NEW YORK NY 10016
Stewart Alan Lonky	director	1158 CHAUTAUQUA BLVD., PACIFIC PALISADES CA 90272
Stanley Jack Cherelstein	director	2401 SW MANOR HILL DRIVE, PALM CITY FL 34990
Michael Flax	director, officer: Chief Financial Officer	2499 BANYAN RD, BOCA RATON FL 33432
Mcclelland David C Sr	director	P.O. BOX 263, FINDLEY LAKE NY 14736
Mitchell S Felder	director	PO BOX 1332, HERMITAGE PA 16148
Khalsa Soram Singh Md	director	436 N BEDFORD DR, BEVERLY HILLS CA 90210

Nutra Pharma (Nutra Pharma) Headlines

From GuruFocus

Nutra Pharma Partners with NxGen Brands for Nyloxin® Distribution

By Marketwired Marketwired • 04-19-2018